FDA recall D-0532-2025 · initiated Jun 20, 2025
May cause temporary or medically reversible harm; low probability of serious harm.
Product Mix Up: This product is being recalled because of a complaint received that a sealed bottle of lisinopril and hydrochlorothiazide tablets 20mg/12.5 mg had a foreign tablet identified as atazanavir and ritonavir tablet 300mg/100mg.